Position in PLRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$470,587
-$49,535 QoQ
Shares Held
412,796
0.0% QoQ
Ownership
0.667%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#29
of 86 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $278,142,488 across 19 Biotechnology names. PLRX ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,352,234 | $100,714,388 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,506,152 | $67,615,980 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
7,820,013 | $44,417,673 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,002,701 | $15,260,581 | |
| 5 | PYXS |
Pyxis Oncology, Inc.
|
4,900,888 | $14,751,672 | |
| 6 | IMUX |
Immunic, Inc.
|
610,326 | $9,380,710 | |
| 7 | AARD |
Aardvark Therapeutics, Inc.
|
1,034,459 | $5,958,483 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
3,316,626 | $5,306,601 |
All Filings in PLRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $470,587 | 412,796 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $520,122 | 412,796 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $314,028 | 257,400 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $26,863,390 | 2,498,920 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $51,773,685 | 3,474,744 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $64,898,398 | 3,583,567 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $55,254,100 | 3,186,511 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $57,233,288 | 3,158,570 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $3,769,514 | 470,601 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||